Results from potentially practice-changing trials of catheter therapies are expected at the American College of Cardiology (ACC) annual conference in New Orleans. These studies include PE Clot-Buster, Impella-Protected PCI, and CAC=0 utility. This is the initial clinical phase of the trials, which will be presented this weekend. The article is published on MedPage Today.